Chemicals and pharmaceuticals · CTLT

Catalent, Inc.

12 filings mentioning 8 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
8topics disclosed
Chemicals and pharmaceuticalsindustry
NJbased in

Across 12 filings we hold, Catalent, Inc. has written down 8 of the topics we track. That places it 210 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

TopicFilingsMost recent
Restatement132024-02-05
Internal Control72024-03-01
Business Continuity62023-06-12
Material Weakness42024-03-01
Enforcement Action32021-11-02
Internal Control Over Financial Reporting Material Weakness12023-06-12
Artificial Intelligence12023-12-08
Data Breach12024-02-05

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24

Recent filings

FiledFormItem
2024-03-018-KChange of accountant, Financial statements and exhibitsfiling
2024-02-058-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2023-12-198-KEntry into a material agreement, Item 2.03, Regulation FD disclosurefiling
2023-12-088-K/AResults of operations, the earnings release, Material impairment, Financial statements and exhibitsfiling
2023-06-278-KEntry into a material agreement, Financial statements and exhibitsfiling
2023-06-1210-K/Afiling
2023-06-128-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-06-1210-Qfiling
2023-05-198-KResults of operations, the earnings release, Delisting or listing rule failure, Financial statements and exhibitsfiling
2022-11-228-KEntry into a material agreement, Item 2.03, Financial statements and exhibitsfiling
2022-11-018-KResults of operations, the earnings release, Shareholder vote, Financial statements and exhibitsfiling
2022-08-2910-Kfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKO HEALTH, INC.12compare →
FIBROGEN INC12compare →
PALATIN TECHNOLOGIES INC12compare →
Oncotelic Therapeutics, Inc.12compare →
NEKTAR THERAPEUTICS12compare →
ALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition